Nicole L. Yates

Duke University — United States

Immunology and Microbiology · Life Sciences

32h-index6.6kcitations101works4.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(88), Immune Cell Function and Interaction(29), HIV/AIDS drug development and treatment(23), HIV/AIDS Research and Interventions(17), Monoclonal and Polyclonal Antibodies Research(16)

Publications100 total

HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trial
Nature Communications·2025Open Access
“I feel like I'm being recognized as being a part of his treatment”: Caregiver perspectives of the serious illness care program for older patients with hematologic malignancies
Blood·2025Open Access
Fixed dosing versus weight-based dosing of HIV-1 prophylactic monoclonal antibodies in adults: a post-hoc, cross-protocol pharmacokinetics modelling study
EBioMedicine·2025Open Access
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans
Science·2025· 30 citedOpen Access
Precise targeting of HIV broadly neutralizing antibody precursors in humans
Science·2025· 22 citedOpen Access
Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines
Frontiers in Immunology·2025· 2 citedOpen Access
Distinct immune responses in people living with HIV following SARS-CoV-2 recovery
UNC Libraries·2025Open Access
Distinct immune responses in people living with HIV following SARS-CoV-2 recovery
Communications Medicine·2025· 1 citedOpen Access
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost
PLOS Global Public Health·2025Open Access
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses
Vaccines·2025· 3 citedOpen Access
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition
UNC Libraries·2025Open Access
Safety, Pharmacokinetics, and Immunogenicity of Combination Long-Acting Broadly Neutralizing Anti-HIV-1 Antibodies 3BNC117-LS and 10-1074-LS in People with and without HIV
SSRN Electronic Journal·2025Open Access
Fixed Dosing Versus Weight-Based Dosing of HIV-1 Prophylactic Monoclonal Antibodies in Adults: A Pharmacokinetics Modeling Study
SSRN Electronic Journal·2025Open Access
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial
The Lancet HIV·2024· 7 citedOpen Access
An Inpatient Advance Care Planning Intervention for Older Patients with Hematologic Malignancies: A Single-Arm Pilot Study
Blood·2024Open Access
Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial
PLOS Global Public Health·2024Open Access
Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV
UNC Libraries·2024Open Access
Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV
Pharmaceutics·2024· 20 citedOpen Access
Computational analysis of antibody dynamics identifies recent HIV-1 infection
UNC Libraries·2023Open Access
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition
EBioMedicine·2023· 30 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Georgia D. Tomaras(48), David C. Montefiori(32), Guido Ferrari(22), Barton F. Haynes(18), Xiaoying Shen(16), Peter B. Gilbert(14), Kelly E. Seaton(14), Allan C. deCamp(13), M. Juliana McElrath(12), S. Munir Alam(11), Punnee Pitisuttithum(10), Supachai Rerks‐Ngarm(10), Nelson L. Michael(10), Michael S. Seaman(9), Sheetal Sawant(9), Lawrence Corey(9), Youyi Fong(8), Richard A. Koup(8), Jaranit Kaewkungwal(8), Sorachai Nitayaphan(8)